US Stock MarketDetailed Quotes
QNRX Quoin Pharmaceuticals
- 0.8099
- -0.0091-1.11%
Close Dec 4 16:00 ET
- 0.7601
- -0.0498-6.15%
Post 20:01 ET
4.09MMarket Cap-221P/E (TTM)
0.8400High0.7500Low740.84KVolume0.7700Open0.8190Pre Close583.19KTurnover15.04%Turnover RatioLossP/E (Static)5.05MShares6.180052wk High0.75P/B3.99MFloat Cap0.477252wk Low--Dividend TTM4.93MShs Float40500.0000Historical High--Div YieldTTM10.99%Amplitude0.4772Historical Low0.7870Avg Price1Lot Size
About Quoin Pharmaceuticals Company
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Company Profile
SymbolQNRX
Company NameQuoin Pharmaceuticals
Listing DateJul 29, 2016
Issue Price6.50
Founded1986
CEOMr. Michael Myers
MarketNASDAQ
Employees4
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address42127 Pleasant Forest Court
CityAshburn
ProvinceVirginia
CountryUnited States of America
Zip Code20148-7349
Phone1-703-980-4182
Websitehttp://www.quoinpharma.com
Company Executives
- Name
- Position
- Salary
- Michael Myers
- Chairman of the Board and Chief Executive Officer
- 1.26M
- Gordon Dunn
- Chief Financial Officer and Principal Accounting Officer
- 775.94K
- Denise Carter
- Director and Chief Operating Officer
- 1.07M
- Dr. Dennis H. Langer, J.D.,M.D.
- Independent Director
- 117.62K
- Natalie Leong
- Independent Director
- 122.62K
- Anthony James Culverwell
- Independent Director
- 122.62K
- Joseph P. Cooper
- Independent Director
- 112.62K
- Michael Sember
- Independent Director
- 107.62K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
